An overview of the evidence and the current recommendations in terms of MHT's role in preventing cardiovascular disease will be discussed as well as its safety in women with pre-existing cardiovascular disease.
Explore "natural oestrogens" as emerging contraceptive options - their biological basis, current evidence, safety claims, and how clinicians can guide patients through informed, evidence-based prescribing decisions.
In this Product Explainer, Gynaecologist Prof Rod Baber AM provides an update on the drospirenone 4mg progestogen-only oral contraceptive pill, including PBS information.
In this Product Explainer, Obstetrician and Gynaecologist Prof Rod Baber provides updates on doses options, PBS information and correct application of 0.1% w/w transdermal estradiol gel for the treatment of menopausal vasomotor symptoms.
In this Quick Case video, Prof Deborah Bateson presents three cases related to recent developments regarding contraception, heavy menstrual bleeding (HMB) and hormone replacement therapy (HRT) to demonstrate the impact on clinical practice
In this Product Explainer, Women’s Health Physician Dr Terri Foran explains the role of prasterone (body-identical DHEA) pessaries for the treatment of moderate to severe vulvovaginal atrophy in postmenopausal women